Celltrion Pharm Inc (068760) — Free Cash Flow Generation Index
Celltrion Pharm Inc (068760) has a Free Cash Flow Generation Index of 0.90x as of September 2025. Free cash flow of ₩21.18 Billion represents 1% of operating cash flow (₩23.44 Billion). See working capital to net assets of Celltrion Pharm Inc to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Celltrion Pharm Inc Free Cash Flow Generation Index (2014–2024)
Historical FCF Generation Index trend for Celltrion Pharm Inc across 8 annual periods. Explore how well can Celltrion Pharm Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Celltrion Pharm Inc (2014–2024)
Year-by-year Free Cash Flow Generation Index for Celltrion Pharm Inc. For the full company profile including market capitalisation, see 068760 market cap.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.89x | ₩50.61 Billion | ₩56.59 Billion | ₩5.98 Billion | ▲ +321.4% |
| 2023 | 0.21x | ₩1.86 Billion | ₩8.76 Billion | ₩6.90 Billion | ▼ -75.5% |
| 2021 | 0.87x | ₩80.65 Billion | ₩93.15 Billion | ₩12.50 Billion | ▲ +491.9% |
| 2020 | -0.22x | ₩-8.01 Billion | ₩36.25 Billion | ₩41.98 Billion | ▼ -110.5% |
| 2019 | 2.09x | ₩58.34 Billion | ₩27.85 Billion | ₩30.49 Billion | ▲ +39.3% |
| 2018 | 1.50x | ₩21.52 Billion | ₩14.31 Billion | ₩7.21 Billion | ▼ -66.1% |
| 2015 | 4.44x | ₩59.33 Billion | ₩13.36 Billion | ₩45.97 Billion | ▲ +76.9% |
| 2014 | 2.51x | ₩43.48 Billion | ₩17.33 Billion | ₩26.16 Billion | — |